PRMT5 Inhibitor Compound Design for Tumor Efficacy and Pharmacokinetics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PRMT5 inhibitors have not been developed and marketed, and there is a need for new compounds with better efficacy and pharmacokinetic results.
Innovation Solution
A novel class of compounds with specific structures is designed as PRMT5 inhibitors, including stereoisomers, geometric isomers, tautomers, pharmaceutical salts, prodrugs, hydrates, and isotope-labeled analogues, which are synthesized through specific processes and shown to have strong inhibitory effects on the PRMT5 enzyme and excellent tumor inhibitory effects in animal models.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing PRMT5 inhibitors are used, then some anti-tumor activity is achieved, but the compounds have not been developed and marketed and lack optimal pharmacokinetic properties
Solution Approach 1:
The patent modifies the molecular structure of PRMT5 inhibitors by changing chemical parameters (substituents at specific positions) to optimize both anti-tumor activity and pharmacokinetic properties. The compound structure includes specific substituents at positions R1-R17 that can be adjusted to achieve desired pharmacokinetic characteristics while maintaining anti-tumor efficacy.
2Reliability
If new PRMT5 inhibitor compounds are developed, then better efficacy and pharmacokinetic results are achieved, but the development process is complex and time-consuming
Solution Approach 1:
The patent divides the complex development process into manageable segments by providing specific structural guidelines and key structural features (KSFs) that can be independently optimized. The compound structure is segmented into core scaffold and substituent portions, allowing systematic exploration of pharmacokinetic and efficacy properties.
Solution Approach 2:
The patent establishes specific parameter ranges and structural constraints (e.g., molecular weight, logP, specific substituent types at defined positions) that simplify the development process by guiding compound selection and optimization toward candidates with optimal properties.
3Reliability
If compound structure is optimized for anti-tumor activity, then tumor inhibitory effects are improved, but metabolic properties may be compromised
Solution Approach 1:
The patent optimizes the balance between tumor inhibitory activity and metabolic stability by adjusting specific structural parameters. The compound structure includes carefully selected substituents and functional groups that enhance anti-tumor efficacy while maintaining favorable metabolic properties, such as appropriate molecular weight and lipophilicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds demonstrate potent in vitro enzyme inhibition and excellent tumor inhibitory effects in xenograft models, with favorable metabolic properties, making them promising candidates for treating PRMT5-mediated diseases.
Implementation Method 1
PRMT5, the abbreviation of the English name Protein arginine N-methyltransferase 5, is one of the protein arginine methyltransferases (PRMTs), and it is a new anti-tumor target related to epigenetic modifications. It has several aliases, namely Hs17, Jbp1, Skb1, Capsuleen or Dart5. PRMT5 is the main enzyme responsible for monomethylation and symmetric dimethylation of arginine.
Data Source
AI summary
Provided is a compound having anti-tumor activity and a use thereof. As a PRMT5 inhibitor, the compound has a structure represented by formula (I). Experiments have confirmed that these compounds have strong inhibitory effects on PRMT5 enzyme activity and tumor cell growth, and can be used as promising compounds for treating PRMT5-mediated diseases. Furthermore, a specific synthesis method is further studied. The synthesis method is simple in process, convenient to operate, and beneficial to large-scale industrial production and application.